Drugs / primalot-nor
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05244811 Comparator | Feb 2022 → Jan 2023 | ovarian neoplasm | Sohag University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | primalot-nor | “primalot-nor” NCT05244811 ↗ |